SHARE

STUDENT SPOTLIGHT

Student Spotlight: Chief Scientist Helps Broaden Biotechnology Field

Bit Bio, the U.K.-based startup, only needed three weeks to raise $41.5 million in a Series A funding round that will be used to support the company’s goal to transition biology into engineering. 

This synthetic biology team was founded by stem cell biologist and neurosurgeon, Mark Kotter, in 2016 to commercialize biotechnology that can reduce the cost and increase the production capacity for differentiated human cells. These cells can be used in targeted therapies and as a method to accelerate pharmaceutical drug discovery. Bit Bio’s goal is to be able to reproduce every human cell type, boosting basic research and enabling a new generation of cell therapies.

How can this type of cell therapy specifically help? By generating every cell type in the human body, this biotechnology will help unlock solutions for tackling cancer, autoimmune diseases and neurodegenerative disorders. Bit Bio’s approach will also help reduce expenses, aid drug discovery, and decrease the reliance on animal studies. 

Quantic alum, Grant Belgard, is the Head of Bioinformatics at Bit Bio. The company’s website explains the centrality of computation: “Bit Bio represents the two fields: coding and biology that determine the identity of every human cell. Ultimately, bits are the building blocks of code, just as cells are the building blocks of life. This is reflective of what Bit Bio does: precise reprogramming of human stem cells.” 

Belgard is also the Chief Scientist and CEO of The Bioinformatics CRO. The company was developed as the subject of his Capstone project in Quantic’s Executive MBA program. The flexibility of the curriculum enabled Belgard to learn, while simultaneously building his new company and pursuing his professional goals.

Now, Belgard’s goal for The Bioinformatics CRO is to streamline biomedical research worldwide. This represents a new breed of contract research organization that offers quality customized bioinformatics services to global biotechnology companies.

Biotechnology companies, like Bit Bio and The Bioinformatics CRO, will help merge biology and engineering and can help bring about long-awaited precision for stem cell research and help improve the lives of millions.

The Quantic community is thrilled for Grant and his colleagues. We can’t wait to see what he does next and how this combination of data science and biology will help code cells for the well-being of humanity.


SHARE

Trending now

STUDENT SPOTLIGHTMay 16, 2022
Quantic Live: A Conversation with Salesforce Director, Grant Glaser

Enjoy our conversation with  Quantic Alum, Salesforce Director and Sales Leader Excellence Coach, Grant Glaser! With over a decade of experience in technology & software, Grant has worked in a variety of roles including, Business Development, Solution Engineering, Learning Design, Strategy, Sales Enablement, and Executive Coaching. Currently, Grant works in leadership development as an executive coach helping new …

STUDENT SPOTLIGHTMay 16, 2022
Introducing Quantic Live: A Conversation with Quantic Alumnus Berthine Crèvecoeur West

Here at Quantic, we are always looking for new ways to connect and celebrate our global network. That’s why we are thrilled to be launching our LinkedIn Live series where we will be featuring stories from students, alumni, and faculty! We are delighted to kick off our first Live with Conflict Resolution/ DEI Strategist, Ceo …

LEADERSHIPMarch 4, 2022
Statement Regarding the Ukraine Crisis

Quantic is a truly global community as our network of students, alumni, and staff span six continents and 151 countries, with students from more countries joining our student body every year. Connectivity that bridges borders and cultures is one of our biggest strengths — if you’re one of our students, you almost certainly have classmates, …

Ready to jump start your career?

Start learning with Quantic.